A Study of CP-751,871 in Patients With Recurrent Squamous Head and Neck Carcinoma

NCT00872404 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

37

Enrollment

OTHER

Sponsor class

Stopped lack of efficacy

Conditions

Head and Neck Cancer

Interventions

DRUG: CP-751,871

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain